投融资数据库
免费查数据
注册送3天会员
首页>投融资
HistoSonics
未公开
HistoSonics is a privately held medical device company developing a non-invasive platform and proprietary sonic beam therapy utilizing the science of histotripsy, a novel mechanism of action that uses focused ultrasound to mechanically destroy and liquify unwanted tissue and tumors at sub-cellular levels.In December 2022, HistoSonics Inc announced raised $85 million in a financing led by Johnson & Johnson Innovation with participation from existing investors including Venture Investors, Lumira Ventures, Yonjin Venture, and the State of Wisconsin Investment Board, among others
基本信息
-
公司全称Histosonics Inc
-
类型机器人辅助声波疗法研发商
-
产业领域医疗器械
-
公司人数15~50人
-
地址3626 West Liberty Road Suite 100 ANN ARBOR MICHIGAN 48103; US; Telephone: +17349264633;
-
联系电话734-926-4630
-
邮箱info@histosonics.com
-
成立时间2009-01-01
投融资
-
2025-10-16
-
2025-08-07
-
2024-08-15
-
2022-12-13
-
2022-12-13
-
2020-06-08
-
2020-01-13
-
2019-04-08
-
2018-07-13
-
2017-03-13
-
2015-09-03
-
2010-04-20
- 加载更多
相关投融资企业
D轮
ViCentra BV develops, manufactures and markets next generation insulin pumps and other products to treat people with diabetes.In December 2021, ViCentra BV announced the closing of a EUR 65 million (USD 74 million) Series C financing
C轮
Inquis Medical是一家专注于外周血管创新的临床阶段医疗器械公司,开发一种外周血栓切除医疗设备,旨在解决未满足的临床需求并提高护理标准。该公司的技术专注于改善静脉血栓栓塞性疾病的管理,并提供有效的单次血栓切除术,减少出血量,使客户能够拥有具有长期影响的医疗设备,以满足未满足的需求。
收并购
Vivasure Medical is a medical device company and developer of absorbable, patch-based closure devices specifically designed to seal large-bore arteriotomies in endovascular procedures.In May 2022, Vivasure Medical closed the first tranche of €22 million as part of its Series D financing round that could reach up to €52 million in total and was led by a multi-national strategic corporation



浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息